Marc M. Lemaître
Chief Operation Officer
Medicine
Suzhou Sirnaomics Bio-pharmaceuticals Co. Ltd
China
Biography
Marc M. Lemaître, Ph.D, Chief Operation Officer, has 30 years of pioneering experience in oligonucleotide development and manufacturing and is the former CEO of Girindus America Inc. and Vorstand of Girindus AG. After pioneering work on Antisense and oligonucleotide delivery in Montpellier, France with Lebleu and Imbach's groups, followed by 2 years in the lab of Nobel Prize winner Dr. Luc Montagnier at the Pasteur Institute in Paris, He moved to the USA in 2006 in a leadership role with Glen Research, before being recruited in 2009 as CEO of Girindus America, a CMO with a focus on the cGMP manufacture of oligonucleotides for therapeutic applications. In this role, Marc also held the legal responsibility of "Sprecher des Vorstands" (President of the management board) of the German listed company Girindus AG, adding invaluable experience of leadership of a public company. Having negotiated the merger between Nitto-Denko Avecia and the US operations of Girindus, working as an independent consultant and joined the Sirnaomics team in 2014.
Research Interest
he mainly focus on the cGMP manufacture of oligonucleotides for therapeutic applications.
